Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
納豆活力寶 is a dietary supplement developed and marketed by Carelife (YOUHUOA Biomedical Co., Ltd.) in Taiwan. The product's primary active ingredient is nattokinase, a potent fibrinolytic enzyme derived from natto, a traditional Japanese fermented soybean dish. Nattokinase acts as a serine protease that directly degrades fibrin, a key component of blood clots, and promotes the body's natural thrombolytic activity by increasing plasmin levels. It is marketed for cardiovascular health, specifically to support healthy blood circulation and prevent thrombus formation. As a consumer-grade health supplement, it is administered orally and is not classified as a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 納豆活力寶.